EPHB4 and colorectal carcinoma: With exogenous cholesterol treatment, EFNB2 knockdown reduced the cholesterol level (Fig. 4H) and blocking EPHB4 inhibited the elevated levels of cholesterol caused by EFNB2 overexpression in FBS-free cultured CRC cells (Fig. 4I).